RealNews

U.S. to Buy Anthrax Vaccine

The government is preparing to buy enough experimental anthrax vaccine for 25 million people, a stockpile that would permit mass inoculations in numerous U.S. cities if terrorists launched a broad assault with the deadly germ. The new vaccine would be the most significant addition to the national anti-terrorism stockpile since the Bush administration fulfilled a pledge to buy enough smallpox vaccine for every citizen of the United States. Up to now, there has been little commercial incentive for companies to develop a modern anthrax vaccine, but the new plan would change that, creating a reserve big enough in a year or two to immunize everyone in the New York and Washington metropolitan areas — or in other cities that might be targeted in an anthrax attack. Full Story

OODA Analyst

OODA Analyst

OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.